Bnp Paribas Asset Management Holding S.A. Teva Pharmaceutical Industries LTD Transaction History

Bnp Paribas Asset Management Holding S.A.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$9.9 - $11.56 $134,362 - $156,892	-13,572 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$10.34 - $12.81 $41,266 - $51,124	-3,991 Reduced 22.72%	13,572 $157,000
Q4 2020 Feb 12, 2021	SELL	$8.61 - $11.04 $100,685 - $129,101	-11,694 Reduced 39.97%	17,563 $169,000
Q3 2020 Nov 09, 2020	BUY	$8.57 - $12.69 $146,821 - $217,405	17,132 Added 141.29%	29,257 $264,000
Q2 2020 Aug 04, 2020	BUY	$8.12 - $13.12 $98,454 - $159,080	12,125 New	12,125 $150,000
Q2 2019 Aug 02, 2019	SELL	$8.12 - $15.72 $228,724 - $442,800	-28,168 Closed	0 $0
Q1 2019 Apr 26, 2019	SELL	$15.58 - $20.01 $84,194 - $108,134	-5,404 Reduced 16.1%	28,168 $442,000
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $236,649 - $386,684	-16,220 Reduced 32.58%	33,572 $527,000
Q2 2018 Aug 01, 2018	SELL	$16.77 - $24.71 $1.27 Million - $1.87 Million	-75,520 Reduced 60.27%	49,792 $1.22 Million
Q1 2018 May 07, 2018	BUY	$16.68 - $22.07 $2.09 Million - $2.77 Million	125,312 New	125,312 $2.14 Million

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.